MOBility Disorders Assessment in Patients With Mild COGnitive Disorders

Last updated: October 11, 2022
Sponsor: University Hospital, Lille
Overall Status: Active - Recruiting

Phase

N/A

Condition

Dementia

Mild Cognitive Impairment

Mental Disability

Treatment

N/A

Clinical Study ID

NCT05273125
2020_55
2021-A00637-34
  • Ages > 65
  • All Genders

Study Summary

Mild cognitive impairment (MCI) is defined by lower performance in one or more cognitive domains with preservation of independence in functional abilities. Sixteen percent of community-dwelling older people (over 65 years) live with MCI. They are both cognitively and physically vulnerable. From a cognitive perspective, they are susceptible to converting to the dementia stage at an annual rate of 10%. From a physical perspective, the proportion of slow gait or neurological gait abnormalities can reach 46% in the population with MCI. Falls in turn increase the risk of accelerated cognitive decline and the risk of institutionalization. In the absence of a curative treatment for dementia, it is essential to have an effective and personalized prevention strategy by identifying the predictive factors for falls in this at-risk population with MCI.

The research goals of this project are 1) to identify specific predictors for falls in clinic attendees with MCI in preparation for a definitive, fully powered study across France, and 2) to demonstrate the feasibility of a pragmatic fall risk assessment in MCs, whatever its setting and location.

We aim to prospectively follow-up people diagnosed with MCI and aged above 65 years old in four MCs in France (three in the North (one community-based MC), and one in the Centre) for one year.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient being diagnosed with MCI, according to the 2011 criteria
  • Able to walk 4 meters with or without technical assistance
  • Comprehension of French language allowing the realization of the neuropsychologicalassessment

Exclusion

Exclusion Criteria:

  • Severe visual or hearing impairment that does not allow the assessment
  • Severe pathology that makes follow-up impossible
  • Administrative reasons: inability to receive informed information, inability toparticipate in the entire study, lack of social security insurance, refusal to signconsent form
  • Under legal protection (guardianship, curatorship, safeguard of justice)

Study Design

Total Participants: 417
Study Start date:
September 09, 2022
Estimated Completion Date:
September 30, 2025

Connect with a study center

  • Hop Salengro - Hopital B

    Lille,
    France

    Active - Recruiting

  • Les Bateliers Chu Lille

    Lille, 59037
    France

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.